Drysdale MJ, Lentzen G, Matassova N, Murchie AIH, Aboul-Ela F, Afshar M. RNA as a drug target.
PROGRESS IN MEDICINAL CHEMISTRY 2003;
39:73-119. [PMID:
12536671 DOI:
10.1016/s0079-6468(08)70069-9]
[Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
In the antiviral and antibacterial area, increasing drug resistance means that there is an ever growing need for novel approaches towards structures and mechanisms which avoid the current problems. The huge increase in high resolution structural data is set to make a dramatic impact on targeting RNA as a drug target. The examples of the RNA binding antibiotics, particularly, the totally synthetic oxazolidinones, should help persuade the skceptics that clinically useful, selective drugs can be obtained from targeting RNA directly.
Collapse